Sara M Mangsbo

Sara M Mangsbo

UNVERIFIED PROFILE

Are you Sara M Mangsbo?   Register this Author

Register author
Sara M Mangsbo

Sara M Mangsbo

Publications by authors named "Sara M Mangsbo"

Are you Sara M Mangsbo?   Register this Author

26Publications

556Reads

47Profile Views

Extracorporeal human whole blood in motion, as a tool to predict first-infusion reactions and mechanism-of-action of immunotherapeutics.

Int Immunopharmacol 2018 Jan 27;54:1-11. Epub 2017 Oct 27.

Immuneed AB, Dag Hammarskjölds väg 13a, Uppsala, Sweden; Department of Pharmaceutical Biosciences, Science for Life Laboratory, Uppsala University, BMC, Husargatan 3, 752 37 Uppsala, Sweden. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.intimp.2017.10.021DOI Listing
January 2018

Local checkpoint inhibition of CTLA-4 as a monotherapy or in combination with anti-PD1 prevents the growth of murine bladder cancer.

Eur J Immunol 2017 02 13;47(2):385-393. Epub 2016 Dec 13.

Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/eji.201646583DOI Listing
February 2017

Tumor-directed immunotherapy can generate tumor-specific T cell responses through localized co-stimulation.

Cancer Immunol Immunother 2017 01 6;66(1):1-7. Epub 2016 Oct 6.

Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-016-1909-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5222923PMC
January 2017

Sunitinib enhances the antitumor responses of agonistic CD40-antibody by reducing MDSCs and synergistically improving endothelial activation and T-cell recruitment.

Oncotarget 2016 Jul;7(31):50277-50289

Department of Immunology, Genetics and Pathology, Science for Life Laboratory, The Rudbeck Laboratory, Uppsala University, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.10364DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226582PMC
July 2016

Antibody induced CD4 down-modulation of T cells is site-specifically mediated by CD64(+) cells.

Sci Rep 2015 Dec 16;5:18308. Epub 2015 Dec 16.

Institute for Experimental Infection Research, TWINCORE, Centre for Experimental and Clinical Infection Research, a joint venture between the Helmholtz Centre for Infection Research (HZI) and the Hannover Medical School (MHH), Feodor-Lynen-Straße 7, D30625 Hannover.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep18308DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4680940PMC
December 2015

The cerebrospinal fluid cytokine signature of multiple sclerosis: a homogenous response that does not conform to the Th1/Th2/Th17 convention.

J Neuroimmunol 2014 Dec 18;277(1-2):153-9. Epub 2014 Oct 18.

Department of Immunology, Genetics and Pathology, Science for Life Laboratories, Uppsala University, Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2014.10.005DOI Listing
December 2014

FcγRIIb on myeloid cells rather than on B cells protects from collagen-induced arthritis.

J Immunol 2014 Jun 19;192(12):5540-7. Epub 2014 May 19.

Department of Human Genetics, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1303272DOI Listing
June 2014

A hexon and fiber-modified adenovirus expressing CD40L improves the antigen presentation capacity of dendritic cells.

J Immunother 2014 Apr;37(3):155-62

Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CJI.0000000000000028DOI Listing
April 2014

Local immunotherapy based on agonistic CD40 antibodies effectively inhibits experimental bladder cancer.

Oncoimmunology 2014 Jan;3(1):e27400

Department of Immunology, Genetics and Pathology; Uppsala University; Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/onci.27400DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3962505PMC
January 2014

Local CTLA4 blockade effectively restrains experimental pancreatic adenocarcinoma growth in vivo.

Oncoimmunology 2014 Jan 16;3(1):e27614. Epub 2014 Jan 16.

Department of Immunology, Genetics and Pathology; Clinical Immunology; Uppsala University; Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/onci.27614DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3962508PMC
January 2014

Locally delivered CD40 agonist antibody accumulates in secondary lymphoid organs and eradicates experimental disseminated bladder cancer.

Cancer Immunol Res 2014 Jan 21;2(1):80-90. Epub 2013 Oct 21.

Authors' Affiliations: Department of Immunotechnology, Lund University, Lund, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-13-0067DOI Listing
January 2014

T-cell responses after haematopoietic stem cell transplantation for aggressive relapsing-remitting multiple sclerosis.

Immunology 2013 Oct;140(2):211-9

Department of Neurosciences, Uppsala University, Uppsala, Sweden; Department of Neurology, Uppsala University Hospital, Uppsala, Sweden; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/imm.12129DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3784167PMC
October 2013

FcγRIIb on myeloid cells and intrinsic renal cells rather than B cells protects from nephrotoxic nephritis.

J Immunol 2013 Jan 30;190(1):340-8. Epub 2012 Nov 30.

Division of Immunity and Inflammation, Department of Medicine, Imperial College London, London W12 0NN, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1202250DOI Listing
January 2013

Fcγ receptor IIb strongly regulates Fcγ receptor-facilitated T cell activation by dendritic cells.

J Immunol 2012 Jul 30;189(1):92-101. Epub 2012 May 30.

Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden 2333 ZA, The Netherlands.

View Article

Download full-text PDF

Source
http://www.jimmunol.org/cgi/doi/10.4049/jimmunol.1103703
Publisher Site
http://dx.doi.org/10.4049/jimmunol.1103703DOI Listing
July 2012

AdCD40L immunogene therapy for bladder carcinoma--the first phase I/IIa trial.

Clin Cancer Res 2010 Jun 4;16(12):3279-87. Epub 2010 May 4.

Division of Urology, Uppsala University, Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-10-0385DOI Listing
June 2010

Complement activation by CpG in a human whole blood loop system: mechanisms and immunomodulatory effects.

J Immunol 2009 Nov 28;183(10):6724-32. Epub 2009 Oct 28.

Department of Oncology, Radiology and Clinical Immunology, Division of Clinical Immunology, Uppsala University, Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://www.jimmunol.org/cgi/doi/10.4049/jimmunol.0902374
Publisher Site
http://dx.doi.org/10.4049/jimmunol.0902374DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2857538PMC
November 2009

Tumor-specific bacteriophages induce tumor destruction through activation of tumor-associated macrophages.

J Immunol 2009 Mar;182(5):3105-11

Department of Oncology and Pathology, Cancer Center Karolinska R8:01, Immune and Gene Therapy Laboratory, Karolinska Institute, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.0800224DOI Listing
March 2009